Abstract
A new anthracycline antibiotic, designated as aclacinomycin X, was isolated from the culture broth of Streptomyces galilaeus ATCC 31133, and was identified as 7-(O-rhodosaminyl-deoxyfucosyl-rednosyl)- aklavinone. Its in vitro cytotoxicity was tested against several human tumor cell lines.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aclarubicin / analogs & derivatives*
-
Aclarubicin / biosynthesis
-
Aclarubicin / chemistry
-
Aclarubicin / isolation & purification
-
Aclarubicin / metabolism
-
Aclarubicin / toxicity
-
Adjuvants, Immunologic / biosynthesis
-
Adjuvants, Immunologic / chemistry
-
Adjuvants, Immunologic / isolation & purification*
-
Adjuvants, Immunologic / toxicity
-
Antibiotics, Antineoplastic / biosynthesis
-
Antibiotics, Antineoplastic / chemistry
-
Antibiotics, Antineoplastic / isolation & purification*
-
Antibiotics, Antineoplastic / toxicity
-
Cell Division / drug effects
-
Culture Media
-
Humans
-
Leukemia / pathology
-
Magnetic Resonance Spectroscopy
-
Melanoma / pathology
-
Streptomyces / metabolism*
-
Tumor Cells, Cultured
Substances
-
11-hydroxyaclacinomycin X
-
Adjuvants, Immunologic
-
Antibiotics, Antineoplastic
-
Culture Media
-
aclacinomycins
-
Aclarubicin